You are here: Industry Insights > china

News List

Motivating Generic Drugs from Multiple Points, China is still a Big Generic Drug Country Muzi
July 10, 2018
China has achieved breakthrough progress in terms of the new drug development speed in recent years, however, China started later than the developed countries in Europe and America in drug development...
Breast cancer is one of the most common cancers in China - and it is on the rise worldpharmanews
July 05, 2018
Among women in China, rates of breast cancer rose around 3.5% each year between 2000 and 2013. In comparison, breast cancer among American women decreased by about 0.4% a year over the same timeframe.
Esco Group to set up innovation centre in China biospectrumasia
July 03, 2018
The 20,00-square-meter manufacturing and innovation complex is scheduled to be completed by end of 2019.
Sanofi Launches Global R&D Ops in China contractpharma
July 03, 2018
Sanofi is launching a Global R&D Operations Hub focused on digitalization and big data analysis in Chengdu, Sichuan province, China.
Yourui Pharma completes Series B financing biospectrumasia
July 02, 2018
Yourui Pharmaceuticals announced that it has been awarded a round of investment by Cambridge Capital to carry out the commercialization of high-value drugs in China
Agilent opens new logistics hub in China biospectrumasia
July 02, 2018
The new centre will enable record on-time delivery of service parts and consumables to the customers, and is a model for the company’s future growth.
CASI, Yiling Wanzhou team up to manufacture entecavir, cilostazol biospectrumasia
June 26, 2018
The contracted manufacturing facilities have been inspected by both the U.S. Food and Drug Administration (FDA) and China FDA (CFDA).
Market leader Novo Nordisk still has lots of upside in China's rapidly growing diabetes market fiercepharma
June 08, 2018
One question Bernstein often gets from investors is why China isn’t a bigger part of Novo Nordisk today, given its large diabetic population.
Roche scrambles to boost Herceptin supply in China after insurance OK triggers shortage fiercepharma
June 06, 2018
When Roche got Herceptin onto China’s national insurance program, it didn’t expect demand to surge so quickly, overwhelming its production capacity there.
Pivotal bioVenture Partners debuts $150M China-focused biotech fund fiercebiotech
May 28, 2018
The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised a $150 million venture fund to help early-stage life science companies located within China.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page